Thermo Fisher Scientific has announced entering into a definitive agreement to acquire CorEvitas, from Audax Private Equity for $912.5 million in cash. The acquisition could close by the end of the year.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,